Events scheduled in Illinois counties near St Louis MO | Belleville News-Democrat
bnd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnd.com Daily Mail and Mail on Sunday newspapers.
Events scheduled in Illinois counties near St Louis MO | Belleville News-Democrat
bnd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnd.com Daily Mail and Mail on Sunday newspapers.
Starving cancer cells of the energy they need to grow could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, according to a new study.
Studying human cancer cells and mice, researchers report that a two-drug combination targeting a tumor’s energy sources could prove as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer.
Osteosarcoma is the most common tumor of the bone in adults and children. It accounts for about 4% of all pediatric cancers and more than half of all pediatric bone cancers. Standard treatment for osteosarcoma includes surgery, radiation, and a cocktail of chemotherapy drugs including high-dose methotrexate, which can cause liver and kidney damage.
Two drugs targeting cancer cells’ energy source potentially could replace toxic chemo in osteosarcoma
January 26, 2021 SHARE A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Shown is a cross section of osteosarcoma. (Image: Richa Rathore)
An innovative approach to treating bone tumors starving cancer cells of the energy they need to grow could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, suggests a new study from Washington University School of Medicine in St. Louis. Studying human cancer cells and mice, the researchers said that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemot